1Professor, Dept. of Ophthalmology, Dr Ram Manohar Lohia Hospital, New Delhi
2Professor, Dept. of Ophthalmology, Dr Ram Manohar Lohia Hospital, New Delhi
3Senior Resident, Dept. of Ophthalmology, Dr Ram Manohar Lohia Hospital, New Delhi
4Associate Professor, Dept. of Home Economics, Delhi University, New Delhi, India
*Corresponding Author: Email: pathakashok22@yahoo.com
Online published on 14 January, 2019.
Acute Herpes Zoster (AHZ) occurs due to reactivation of dormant Varicella zoster virus within neurons. It is more common in the elderly diabetics and immuno-compromised patients. Such patients are more likely to develop debilitating neuropathic pain known as post herpetic neuralgia (PHN). Various researchers suggest that early antiviral treatment can prevent development of PHN and reduce it's severity when it does occur. A retrospective study on 45 patients of herpes zoster ophthalmicus treated with oral acyclovir of different strengths with or without systemic steroid were evaluated for post herpetic neuralgia at repeated intervals for one Year in herpes zoster ophthalmicus cases. Our study suggests that a combination of antiviral drugs and steroid may have the best results in the management of PHN.
Herpes zoster ophthalmicus, Post herpetic neuralgia, Painscore, Treatment
